Article Information
History
- December 21, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Vilde Bergstad Larsen1,
- Nina Gunnes2,3,
- Jon Michael Gran4,
- Jesper Dahl5,
- Håkon Bøås5,
- Sara Viksmoen Watle5,
- Jacob Dag Berild5,
- Margrethe Greve-Isdahl5,
- Ketil Størdal6,
- Hanne Løvdal Gulseth2,
- Øystein Karlstad2,
- Paz Lopez-Doriga Ruiz2,7 and
- German Tapia2,*
- 1Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway
- 2Division of Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway
- 3Norwegian Research Centre for Women’s Health, Oslo University Hospital, Oslo, Norway
- 4Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Oslo, Norway
- 5Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
- 6Department of Pediatric Research, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Oslo, Norway
- 7Institute of Community Health and Global Medicine, University of Oslo, Oslo, Norway
- ↵*Corresponding author: German Tapia, Norwegian Institute of Public Health, Marcus Thranes gate 6, 0473 Oslo, Norway; (german.tapia{at}fhi.no)
Posted December 21, 2023.
Adverse Events Following SARS-CoV-2 mRNA Vaccination in Adolescents: A Norwegian Nationwide Register-Based Study
